Picture of Consun Pharmaceutical logo

1681 — Consun Pharmaceutical News Story

0.000.00%
hk flag iconLast trade - 00:00
HealthcareBalancedMid CapSuper Stock

Brief: Consun Pharmaceutical Group Sees Decrease Of About 70% To 80% In FY19 Profit Attributable

Jan 9 (Reuters) - Consun Pharmaceutical Group Ltd  1681.HK :
    * EXPECTED THAT PROFIT ATTRIBUTABLE FOR FY2019 WOULD RECORD
A
DECREASE OF APPROXIMATELY 70% TO 80%
    * EXPECTED RESULT DUE TO DECREASE IN SALES REVENUE OF YULIN
PHARMACEUTICAL SEGMENT
    * EXPECTED TO RECORD DECREASE OF JUST LESS THAN 10% IN TOTAL
SALES
REVENUE FOR FY2019 AS COMPARED TO THAT FOR FY2018

Source text for Eikon:  ID:nHKS6ZSVY3 
Further company coverage:  1681.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Consun Pharmaceutical

See all news